3 weeks Wall Street Analysts Think Bioventus (BVS) Could Surge 26.03%: Read This Before Placing a Bet Zacks
The average of price targets set by Wall Street analysts indicates a potential upside of 26% in Bioventus (BVS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
X